The issuer is solely responsible for the content of this announcement.

Optometrist Lim Yan Yi sheds light on common vision problems affecting children and red flags that shouldn't be ignored.

The trial will enrol up to 70 patients with refractory glaucoma and has a 12-month primary effectiveness endpoint.

Opus Genetics is conducting a trial for OPGx-MERTK gene therapy in Abu Dhabi, targeting MERTK-related retinitis pigmentosa ...

Myra Vision's Calibreye aqueous shunt for glaucoma patients is designed to provide adjustable and reversible outflow control.

Myra Vision has treated the first patient in its ADAPT clinical study evaluating the Calibreye TGT Surgical System in ...

The MarketWatch News Department was not involved in the creation of this content.-- Initial case conducted by Dr. David Godfrey at Glaucoma Associates of Texas -- The IDE study wi ...

A research team at the WVU is studying how to restore vision in people who develop a form of inherited blindness. Visvanathan Ramamurthy, professor and chair of the Department of Biochemistry and ...

Caroline Igo (she/her/hers) was a wellness editor at CNET and holds Sleep Science Coach and Stress Management certificates from the Spencer Institute. She received her bachelor's degree in creative ...